Here are some of the latest health and medical news
developments, compiled by the editors of HealthDay:
U.S. Company Donates Hemophilia Drugs to Poor Nations
A U.S. biotechnology company says it will donate hundreds of
millions of dollars worth of hemophilia drugs to developing
Biogen Idec Inc. of Cambridge, Mass. pledged to give 1 billion
units of clotting factor to poor nations in Africa, Asia and Latin
America over the next 10 years, the
People with hemophilia lack proteins required to control
bleeding. Clotting factor helps prevent uncontrollable bleeding in
patients with the inherited disorder. A person with severe
hemophilia may use up to 5,000 units of clotting factor a week.
Many hemophilia patients in poor countries can't afford
treatment. As a result, most don't live into adulthood, according
to Dr. David Kuter, chief of hematology at Massachusetts General
Biogen's announcement of its donation coincides with its launch
of new hemophilia drugs, the
Oil and Gas Wells on Federal, Indian Lands Lack Oversight:
Thousands of high-risk oil and gas wells on federal government
and Indian lands have not been inspected by the Interior
Department's Bureau of Land Management, according to a Government
Accountability Office report.
The audit said that weak oversight of wells that pose
potentially high risks for water contamination and other
environmental harm is due to incomplete monitoring data and
policies based on outdated science, the
The congressional investigators also said that the Bureau of
Land Management failed to coordinate effectively with state
regulators in New Mexico, North Dakota, Oklahoma and Utah.
The GAO said the bureau "cannot accurately and efficiently
identify whether federal and Indian resources are properly
protected or that federal and Indian resources are at risk of being
extracted without agency approval."